Genes contribute to the risk of celiac disease (CD), but the role of environmental factors, including perturbations in gut microbiota, is so far unclear.
This article, published in Cell Host & Microbe, looked at human immunodeficiency virus, type 1 (HIV-1) Envelope gp41 antibodies. (Gp41 is a protein on the surface of HIV that helps the virus invade the host's cells; it is of interest to
I participated in the "Targeting microbiota" congress at Pasteur Institute because I considered the topics discussed very interesting and relevant to my research. For me microbiome conferences are still a rather foreign territory, but I very much like to talk
At the occasion of the "New therapies in coeliac disease" conference hosted by Columbia University in New-York on March 20, 2014, Dr. Elena Verdú, our expert in Nutrition, is sharing with us the last trends in research in the field of
Dr Elena Verdú's lab seeks to understand the complex pathophysiology of gastrointestinal disease, with a focus on microbiota-diet interactions, to identify novel therapeutic targets for these disorders. 1/ What strikes you most in the evolution of research on
Cancer chemotherapy: when intestinal bacteria provide a reinforcement
28 Nov 2013by GMFH Editing Team
[This article is an outside contribution by Dr Patricia Lepage (INRA), co-author of the paper. For further references about the author, see the short bio hereunder] Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and
Humans are not (and have never been) alone. From the moment we are born, millions of micro-organisms populate our bodies and coexist with us rather peacefully for the rest of our lives. This microbiome represents the totality of micro-organisms (and
